{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:47:30Z","timestamp":1791989250848,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Equity Health"],"DOI":"10.1186\/s12939-026-02948-2","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:54:51Z","timestamp":1784303691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Do subsidies reach the sick? Implementation challenges and equity implications of pharmaceutical subsidy reform in Iran: a qualitative study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6988-3759","authenticated-orcid":false,"given":"Anahita","family":"Behzadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8199-5462","authenticated-orcid":false,"given":"Amirhossein","family":"Fatahpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7861-4692","authenticated-orcid":false,"given":"Maliheh","family":"Ghobadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1267-4382","authenticated-orcid":false,"given":"Maryam","family":"Amiresmaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2948_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2147\/CEOR.S413546","volume":"15","author":"A Yenet","year":"2023","unstructured":"Yenet A, Nibret G, Tegegne BA. Challenges to the availability and affordability of essential medicines in African countries: a scoping review. Clinicoecon Outcomes Res. 2023;15:443\u201358. https:\/\/doi.org\/10.2147\/CEOR.S413546.","journal-title":"Clinicoecon Outcomes Res"},{"key":"2948_CR2","doi-asserted-by":"publisher","unstructured":"Masefield SC, Msosa A, Chinguwo FK, Grugel J. Stakeholder engagement in the health policy process in a low income country: a qualitative study of stakeholder perceptions of the challenges to effective inclusion in Malawi. BMC Health Serv Res. 2021;21(1):984. https:\/\/doi.org\/10.1186\/s12913-021-07016-9.","DOI":"10.1186\/s12913-021-07016-9"},{"issue":"1","key":"2948_CR3","doi-asserted-by":"publisher","first-page":"2550370","DOI":"10.1080\/20523211.2025.2550370","volume":"18","author":"YSL Loh","year":"2025","unstructured":"Loh YSL, Koh SGM, Siah AKL, Cheong WL, Su TT. Stakeholder engagement and pharmaceutical pricing regulation: a qualitative inquiry. J Pharm Policy Pract. 2025;18(1):2550370. https:\/\/doi.org\/10.1080\/20523211.2025.2550370.","journal-title":"J Pharm Policy Pract"},{"issue":"7","key":"2948_CR4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/heapol\/czs108","volume":"28","author":"M Bigdeli","year":"2013","unstructured":"Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, et al. Access to medicines from a health system perspective. Health Policy Plan. 2013;28(7):692\u2013704. https:\/\/doi.org\/10.1093\/heapol\/czs108.","journal-title":"Health Policy Plan"},{"key":"2948_CR5","doi-asserted-by":"publisher","DOI":"10.1596\/13734","volume-title":"World Bank pharmaceuticals","author":"MR Reich","year":"2000","unstructured":"Reich MR, Govindaraj R, Cohen JC. World Bank pharmaceuticals. Washington, DC: World Bank; 2000."},{"issue":"1","key":"2948_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/hpm.2605","volume":"34","author":"M Bazyar","year":"2019","unstructured":"Bazyar M, Rashidian A, Sakha MA, Doshmangir L, Rahimi N, Ranjbar M, et al. Stakeholders analysis of merging social health insurance funds in Iran: What kind of interests they may gain or lose? Health Plann Manag. 2019;34(1):157\u201376. https:\/\/doi.org\/10.1002\/hpm.2605.","journal-title":"Health Plann Manag"},{"issue":"11","key":"2948_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2471\/BLT.17.206516","volume":"96","author":"A Paschke","year":"2018","unstructured":"Paschke A, Dimancesco D, Vian T, Kohler JC, Forte G. Increasing transparency and accountability in national pharmaceutical systems. Bull World Health Organ. 2018;96(11):782\u201391. https:\/\/doi.org\/10.2471\/BLT.17.206516.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2948_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40545-021-00371-2","volume":"14","author":"A Kadkhodamanesh","year":"2021","unstructured":"Kadkhodamanesh A, Varahrami V, Zarei L, Peiravian F, Hadidi M, Yousefi N. Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries. J Pharm Policy Pract. 2021;14(1):82. https:\/\/doi.org\/10.1186\/s40545-021-00371-2.","journal-title":"J Pharm Policy Pract"},{"issue":"5","key":"2948_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.15171\/ijhpm.2017.147","volume":"7","author":"F Kokabisaghi","year":"2018","unstructured":"Kokabisaghi F. Assessment of the effects of economic sanctions on Iranians\u2019 right to health by using human rights Impact assessment tool: a systematic review. Int J Health Policy Manag. 2018;7(5):374\u201393. https:\/\/doi.org\/10.15171\/ijhpm.2017.147.","journal-title":"Int J Health Policy Manag"},{"issue":"2","key":"2948_CR10","first-page":"45","volume":"25","author":"H Pourasghari","year":"2022","unstructured":"Pourasghari H, Saadati M, Moradi N, Rezapour A, Yousefzadeh N, Dehnad A, et al. Policy analysis of allocating the subsidized currency to medication in Iran and development of political alternatives. J Health Adm. 2022;25(2):45\u201361.","journal-title":"J Health Adm"},{"issue":"1","key":"2948_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12961-021-00762-6","volume":"19","author":"A Olyaaeemanesh","year":"2021","unstructured":"Olyaaeemanesh A, Jaafaripooyan E, Abdollahiasl A, Davari M, Mousavi SM, Delpasand M. Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis. Health Res Policy Sys. 2021;19(1):150. https:\/\/doi.org\/10.1186\/s12961-021-00762-6.","journal-title":"Health Res Policy Sys"},{"key":"2948_CR12","doi-asserted-by":"publisher","unstructured":"Moeini S, Ahmadi Teymourlouy A, Abolghasem Gorji H, Kabir MJ. Reforming drug subsidies in Iran: structural legacies and the implementation challenge of the darooyar plan. Iran Red Crescent Med J (IRCMJ). 2025;27(1). https:\/\/doi.org\/10.22034\/ircmj.2025.520260.2128.","DOI":"10.22034\/ircmj.2025.520260.2128"},{"key":"2948_CR13","doi-asserted-by":"publisher","unstructured":"Charbonneau M, Morgan SG, Gagnon C, Sadowski CA, Silvius JL, Tannenbaum C, et al. Factors influencing the effects of policies and interventions to promote the appropriate use of medicines in high-income countries: a rapid realist review. In: Health policy. Vol. 142. Amsterdam, Netherlands; 2024. p. 105027. https:\/\/doi.org\/10.1016\/j.healthpol.2024.105027.","DOI":"10.1016\/j.healthpol.2024.105027"},{"issue":"2","key":"2948_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1071\/ah13240","volume":"38","author":"W Lipworth","year":"2014","unstructured":"Lipworth W, Doran E, Kerridge I, Day R. Challenges to pharmaceutical policymaking: lessons from Australia\u2019s national medicines policy. Aust Health Rev. 2014;38(2):160\u201368. https:\/\/doi.org\/10.1071\/ah13240.","journal-title":"Aust Health Rev"},{"issue":"10","key":"2948_CR15","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/jac5.1441","volume":"4","author":"OA Adeoye-Olatunde","year":"2021","unstructured":"Adeoye-Olatunde OA, Olenik NL. Research and scholarly methods: semi-structured interviews. 2021. JACCP: J Am Coll Clin Pharm. 2021;4(10):1358\u201367. https:\/\/doi.org\/10.1002\/jac5.1441.","journal-title":"JACCP: J Am Coll Clin Pharm"},{"issue":"2","key":"2948_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Phychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qualitative Res Phychol"},{"issue":"5","key":"2948_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative Data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533\u201344. https:\/\/doi.org\/10.1007\/s10488-013-0528-y.","journal-title":"Adm Policy Ment Health"},{"issue":"3","key":"2948_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1177\/1049732317697102","volume":"28","author":"J Phillippi","year":"2018","unstructured":"Phillippi J, Lauderdale J. A Guide to field notes for qualitative research: context and conversation. Qual Health Res. 2018;28(3):381\u201388. https:\/\/doi.org\/10.1177\/1049732317697102.","journal-title":"Qual Health Res"},{"issue":"4","key":"2948_CR19","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893\u2013907. https:\/\/doi.org\/10.1007\/s11135-017-0574-8.","journal-title":"Qual Quant"},{"issue":"1","key":"2948_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/13814788.2017.1375092","volume":"24","author":"I Korstjens","year":"2018","unstructured":"Korstjens I, Moser A. Series: practical guidance to qualitative research. Part 4: trustworthiness and publishing. The Eur J Gener Pract. 2018;24(1):120\u201324. https:\/\/doi.org\/10.1080\/13814788.2017.1375092.","journal-title":"The Eur J Gener Pract"},{"issue":"1","key":"2948_CR21","doi-asserted-by":"publisher","first-page":"2350649","DOI":"10.1080\/17441692.2024.2350649","volume":"19","author":"A Wong","year":"2024","unstructured":"Wong A, Perehudoff K, Kohler JC. Legislating for good governance in the pharmaceutical sector through UN convention against corruption (UNCAC) compliance. Global Public Health. 2024;19(1):2350649. https:\/\/doi.org\/10.1080\/17441692.2024.2350649.","journal-title":"Global Public Health"},{"issue":"1","key":"2948_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s44259-024-00061-4","volume":"2","author":"D Panteli","year":"2024","unstructured":"Panteli D, Anderson M, Fieldman T, Baraldi E, T\u00e4ngd\u00e9n T, Vogler S, et al. Policy options for sustainable access to off-patent antibiotics in Europe. npj antimicrobials and resistance. 2024. Npj Antimicrobials Resist. 2024;2(1):40. https:\/\/doi.org\/10.1038\/s44259-024-00061-4.","journal-title":"Npj Antimicrobials Resist"},{"issue":"1","key":"2948_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12961-024-01138-2","volume":"22","author":"RN Bigirinama","year":"2024","unstructured":"Bigirinama RN, Mothupi MC, Mwene-Batu PL, Kozuki N, Chiribagula CZ, Chimanuka CM, et al. Prioritization of maternal and newborn health policies and their implementation in the eastern conflict affected areas of the democratic republic of congo: a political economy analysis. Health Res Policy Sys. 2024;22(1):55. https:\/\/doi.org\/10.1186\/s12961-024-01138-2.","journal-title":"Health Res Policy Sys"},{"key":"2948_CR24","doi-asserted-by":"publisher","unstructured":"Lotfian A, Moghri J. Structural challenges and strategic responses in Iran\u2019s COVID-19 management: insights from healthcare experts. BMC Public Health. 2026;26(1). https:\/\/doi.org\/10.1186\/s12889-026-26860-0.","DOI":"10.1186\/s12889-026-26860-0"},{"key":"2948_CR25","doi-asserted-by":"publisher","first-page":"1704501","DOI":"10.3389\/fpubh.2026.1704501","volume":"14","author":"C Wang","year":"2026","unstructured":"Wang C, Xu M, Xu M. Study on the spillover effects of tail risks in the supply chain of China\u2019s pharmaceutical industry. Front Public Health. 2026;14:1704501. https:\/\/doi.org\/10.3389\/fpubh.2026.1704501.","journal-title":"Front Public Health"},{"issue":"1","key":"2948_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/0125899775394503250626070441","volume":"18","author":"U Agarwal","year":"2026","unstructured":"Agarwal U, Kapoor G, Singhal K, Tonk RK. The pharmacoeconomics and its evaluation in enhancing the Indian healthcare system. Curr Drug Res Rev. 2026;18(1):106\u201320. https:\/\/doi.org\/10.2174\/0125899775394503250626070441.","journal-title":"Curr Drug Res Rev"},{"key":"2948_CR27","doi-asserted-by":"publisher","unstructured":"Moradi F, Bazyar M, Soroush A, Seyedin H, Soleymani F, Etemadi M, et al. Understanding conflicts of interest in rational drug prescription in a developing country: a stakeholder analysis, healthcare guidelines and ethical public health issues. J Prev Med Hyg. 2023;64(3):E358\u2013e66. https:\/\/doi.org\/10.15167\/2421-4248\/jpmh2023.64.3.3036.","DOI":"10.15167\/2421-4248\/jpmh2023.64.3.3036"},{"issue":"2","key":"2948_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/nu13020457","volume":"13","author":"S Ng","year":"2021","unstructured":"Ng S, Kelly B, Yeatman H, Swinburn B, Karupaiah T. Tracking progress from policy development to implementation: a case study on adoption of mandatory regulation for nutrition labelling in Malaysia. Nutrients. 2021;13(2):457. https:\/\/doi.org\/10.3390\/nu13020457.","journal-title":"Nutrients"},{"key":"2948_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.12688\/wellcomeopenres.24152.2","volume":"10","author":"RR Basapathy","year":"2025","unstructured":"Basapathy RR, Mathur MR. Strengthening governance for universalising primary oral health Care: perspectives from Karnataka, India. Wellcome Open Res. 2025;10:305. https:\/\/doi.org\/10.12688\/wellcomeopenres.24152.2.","journal-title":"Wellcome Open Res"},{"key":"2948_CR30","doi-asserted-by":"publisher","unstructured":"Bigdeli M, Rouffy B, Lane BD, Schmets G, Soucat A. Health systems governance: the missing links. BMJ Glob Health. 2020;5(8):e002533. https:\/\/doi.org\/10.1136\/bmjgh-2020-002533.","DOI":"10.1136\/bmjgh-2020-002533"},{"key":"2948_CR31","doi-asserted-by":"publisher","unstructured":"Herrera CA, Lewin S, Paulsen E, Ciapponi A, Opiyo N, Pantoja T, et al. Governance arrangements for health systems in low-income countries: an overview of systematic reviews. The cochrane database of systematic reviews. 2017. Cochrane Database Systematic Rev. 2017;2017(9):Cd011085. https:\/\/doi.org\/10.1002\/14651858.cd011085.pub2.","DOI":"10.1002\/14651858.cd011085.pub2"},{"issue":"1","key":"2948_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12992-021-00753-w","volume":"17","author":"Z Chang","year":"2021","unstructured":"Chang Z, Rusu V, Kohler JC. The global fund: why anti-corruption, transparency and accountability matter. Globalizat Health. 2021;17(1):108. https:\/\/doi.org\/10.1186\/s12992-021-00753-w.","journal-title":"Globalizat Health"},{"key":"2948_CR33","doi-asserted-by":"publisher","unstructured":"Gorodensky A, Bowra A, Saeed G, Kohler J. Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations. BMJ Open. 2022;12(12):e064137. https:\/\/doi.org\/10.1136\/bmjopen-2022-064137.","DOI":"10.1136\/bmjopen-2022-064137"},{"issue":"6","key":"2948_CR34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/heapol\/czaf022","volume":"40","author":"P Aivalli","year":"2025","unstructured":"Aivalli P, Dada S, Gilmore B, Srinivas PN, De Br\u00fan A. Power dynamics and intersectoral collaboration for health in low- and middle-income countries: a realist review. Health Policy Plan. 2025;40(6):661\u201383. https:\/\/doi.org\/10.1093\/heapol\/czaf022.","journal-title":"Health Policy Plan"},{"issue":"3","key":"2948_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/heapol\/czaf113","volume":"41","author":"B Anderson","year":"2026","unstructured":"Anderson B, McKee M, Agwu P, Balabanova D. Measuring and assessing corruption in public health systems in low- and middle-income countries: a scoping review of methods. Health Policy Plan. 2026;41(3):460\u201370. https:\/\/doi.org\/10.1093\/heapol\/czaf113.","journal-title":"Health Policy Plan"},{"issue":"4","key":"2948_CR36","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/jeea\/jvy017","volume":"16","author":"L Einav","year":"2018","unstructured":"Einav L, Finkelstein A. Moral hazard in health insurance: what we know and how we know it. J Eur Econ Assoc. 2018;16(4):957\u201382. https:\/\/doi.org\/10.1093\/jeea\/jvy017.","journal-title":"J Eur Econ Assoc"},{"issue":"1","key":"2948_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.18553\/jmcp.2022.21270","volume":"29","author":"N Fusco","year":"2023","unstructured":"Fusco N, Sils B, Graff JS, Kistler K, Ruiz K. Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: a systematic literature review. JMCP. 2023;29(1):4\u201316. https:\/\/doi.org\/10.18553\/jmcp.2022.21270.","journal-title":"JMCP"},{"issue":"7","key":"2948_CR38","doi-asserted-by":"publisher","first-page":"738","DOI":"10.18553\/jmcp.2019.25.7.738","volume":"25","author":"K Yeung","year":"2019","unstructured":"Yeung K. Value-based insurance design: current evidence and future directions. JMCP. 2019;25(7):738\u201341. https:\/\/doi.org\/10.18553\/jmcp.2019.25.7.738.","journal-title":"JMCP"},{"key":"2948_CR39","doi-asserted-by":"publisher","first-page":"469580261441100","DOI":"10.1177\/00469580261441100","volume":"63","author":"K Shi","year":"2026","unstructured":"Shi K, Wang Y, Jing T, Ma G, Xu W, Du W. Expanding outpatient benefit package without increasing total spending: evidence from outpatient benefit reform for non-chronic disease patients. Inq: J Med Care Organ, Provision Financing. 2026;63:469580261441100. https:\/\/doi.org\/10.1177\/00469580261441100.","journal-title":"Inq: J Med Care Organ, Provision Financing"},{"issue":"5","key":"2948_CR40","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/hec.70083","volume":"35","author":"G Majewska","year":"2026","unstructured":"Majewska G, Zaremba K. The financial and behavioral effects of free prescription drugs: evidence from a policy discontinuity in Poland. Health Econ. 2026;35(5):796\u2013830. https:\/\/doi.org\/10.1002\/hec.70083.","journal-title":"Health Econ"},{"issue":"2","key":"2948_CR41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.30476\/ijms.2021.89901.2078","volume":"47","author":"P Bastani","year":"2022","unstructured":"Bastani P, Dehghan Z, Kashfi SM, Dorosti H, Mohammadpour M, Mehralian G. Challenge of politico-economic sanctions on pharmaceutical procurement in Iran: a qualitative study. Iran J Med Sci. 2022;47(2):152\u201361. https:\/\/doi.org\/10.30476\/ijms.2021.89901.2078.","journal-title":"Iran J Med Sci"},{"issue":"1","key":"2948_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12992-016-0168-6","volume":"12","author":"S Setayesh","year":"2016","unstructured":"Setayesh S, Mackey TK. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy. Globalizat Health. 2016;12(1):31. https:\/\/doi.org\/10.1186\/s12992-016-0168-6.","journal-title":"Globalizat Health"},{"issue":"1","key":"2948_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40545-021-00341-8","volume":"14","author":"P Bastani","year":"2021","unstructured":"Bastani P, Dehghan Z, Kashfi SM, Dorosti H, Mohammadpour M, Mehralian G, et al. Strategies to improve pharmaceutical supply chain resilience under politico-economic sanctions: the case of Iran. J Pharm Policy Pract. 2021;14(1):56. https:\/\/doi.org\/10.1186\/s40545-021-00341-8.","journal-title":"J Pharm Policy Pract"},{"issue":"1","key":"2948_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5334\/ijic.7610","volume":"24","author":"J Exley","year":"2024","unstructured":"Exley J, Glover R, McCarey M, Reed S, Ahmed A, Vrijhoef H, et al. Governing integrated health and social Care: an analysis of experiences in three European countries. Int J Integr Care. 2024;24(1):9. https:\/\/doi.org\/10.5334\/ijic.7610.","journal-title":"Int J Integr Care"}],"container-title":["International Journal for Equity in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12939-026-02948-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-026-02948-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-026-02948-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:10:25Z","timestamp":1791987025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12939-026-02948-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2948"],"URL":"https:\/\/doi.org\/10.1186\/s12939-026-02948-2","relation":{},"ISSN":["1475-9276"],"issn-type":[{"value":"1475-9276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study proposal was approved by the Ethics Committee of Kerman University of Medical Sciences under the ethics code IR.KMU.REC.1401.547 (proposal registration number: 401,000,810).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to the interviews.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"241"}}